Search Results 21-30 of 13440 for Relaxin-2
About this study. The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in ...
... 2 dose (RP2D) for future study after treatment with SONALA-001 in combination ... Go to page 22 · Go to page 33 · Go to page 44 · Go to page 55 · NextNext Page.
... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...
... (2) improves stroke outcomes at 3 months in patients who experienced an ... Devices used for microperfusion are Joanneum Research's cerebral open flow ...
Stage 2: two or more positive diabetes autoantibodies and asymptomatic dysglycemia (fasting glucose, 100-125 mg/dL; two-hour glucose, 140-199 mg/dL; or A1C ...
The field of interstitial lung disease (ILD) management continues to evolve. Mayo Clinic pulmonary medicine physicians are particularly excited about two ...
... 2 {Mobitz 2} or third degree AV-block]);; Significant symptoms (Grade ≥ 2) relating to left ventricular dysfunction, cardiac arrhythmia, or cardiac ischemia; ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...
It happens most often when you take two medicines that both raise serotonin levels. This includes taking an SNRI with other antidepressants, certain pain or ...
... (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A study to create and analyze a comprehensive longitudinal resource ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.